<p>Privia Health Group（纳斯达克代码：PRVA - 获取免费报告）在周四发布的报告中，Truist Financial 的股票分析师将其目标价格从 27.00 美元上调至 28.00 美元，Benzinga 报道。该券商目前对该股票给予 “买入” 评级。Truist Financial 的目标价格意味着该股票相较于之前的收盘价有 22.83% 的潜在上涨空间。</p>
<p>获取 <strong>Privia Health Group</strong> 的提醒：</p>
<p>PRVA 近期成为多篇报告的主题。Stephens 在 1 月 2 日的报告中重新发布了 “超配” 评级，并将 Privia Health Group 的目标价格设定为 26.00 美元。Canaccord Genuity Group 在 2 月 28 日的研究报告中将 Privia Health Group 的目标价格从 29.00 美元上调至 30.00 美元，并给予该公司 “买入” 评级。Macquarie 在 12 月 16 日的研究报告中开始覆盖 Privia Health Group，给予 “跑赢大盘” 评级和 25.00 美元的价格目标。Piper Sandler 在 2 月 28 日的报告中将 Privia Health Group 的目标价格从 25.00 美元上调至 40.00 美元，并给予该公司 “超配” 评级。最后，JMP Securities 在 2 月 28 日的研究报告中将 Privia Health Group 的目标价格设定为 29.00 美元。一位股票研究分析师对该股票给予持有评级，十三位给予买入评级，两位给予强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “买入”，共识目标价格为 26.73 美元。</p>
<p><strong>查看我们关于 Privia Health Group 的最新股票报告</strong></p>
<h2>Privia Health Group 股价下跌 1.1%</h2>
<p>PRVA 股票在周四开盘价为 22.80 美元。该公司的 50 日简单移动平均线为 23.73 美元，200 日简单移动平均线为 21.41 美元。Privia Health Group 的 1 年最低价为 15.92 美元，1 年最高价为 26.04 美元。该公司的市值为 27.7 亿美元，市盈率为 227.97，市盈增长比率为 3.47，贝塔值为 0.88。</p>
<h2>Privia Health Group 的内部活动</h2>
<p>在其他新闻中，首席财务官 David Mountcastle 在 4 月 2 日（星期三）出售了 5,630 股公司的股票。股票以平均价格 22.38 美元出售，总价值为 125,999.40 美元。交易完成后，首席财务官现在持有 179,676 股公司股票，价值为 4,021,148.88 美元。此交易代表其持股减少了 3.04%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。公司内部人士目前持有 14.20% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者和对冲基金最近对 PRVA 的持仓进行了调整。Rhumbline Advisers 在第四季度将其在 Privia Health Group 的持仓增加了 1.3%。Rhumbline Advisers 现在持有 287,200 股公司股票，价值为 5,615,000 美元，此前在上个季度又购买了 3,658 股。Nordea Investment Management AB 在第四季度将其在 Privia Health Group 的股份增加了 33.1%。Nordea Investment Management AB 现在持有 349,773 股公司股票，价值为 6,953,000 美元，此前在上个季度又购买了 86,910 股。Franklin Resources Inc.在第三季度将其在 Privia Health Group 的持股增加了 2.2%。Franklin Resources Inc.现在持有 1,300,240 股公司股票，价值为 23,092,000 美元，此前在上个季度又购买了 28,480 股。巴克莱银行在第三季度将其在 Privia Health Group 的持股增加了 240.3%。巴克莱银行现在持有 224,018 股公司股票，价值为 4,079,000 美元，此前在上个季度又购买了 158,188 股。最后，摩根大通在第三季度将其在 Privia Health Group 的持股增加了 8.4%。摩根大通现在持有 188,384 股公司股票，价值为 3,430,000 美元，此前在上个季度又购买了 14,641 股。对冲基金和其他机构投资者持有公司 94.48% 的股票。</p>
<h2>关于 Privia Health Group</h2>
<p>（获取免费报告）</p>
<p>Privia Health Group, Inc 在美国作为一家全国性的医生赋能公司运营。该公司与医疗集团、健康计划和健康系统合作，以优化医生实践、提升患者体验，并奖励医生在面对面和虚拟环境中提供护理。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，优于 Privia Health Group</li>
<li>纽约证券交易所和纳斯达克的区别，以及这对投资者的重要性</li>
<li>博通的强劲表现显示出关税下降中的韧性</li>
<li>选举股票：选举如何影响股市</li>
<li>Carvana：能否在逆风中实现反转？</li>
<li>如何利用分析师评级进行交易</li>
<li>Meta 在 FTC 审判中寻求特朗普的帮助：影响巨大</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Privia Health Group 吗？</h2>
<p>在考虑 Privia Health Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Privia Health Group 并不在名单上。</p>
<p>虽然 Privia Health Group 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

PRVA

<p>Truist Financial 将 Privia Health Group (NASDAQ:PRVA) 的目标价格从 27.00 美元上调至 28.00 美元，维持 “买入” 评级。这个新目标暗示该股票相较于之前的收盘价有 22.83% 的潜在上涨空间。其他分析师也给予了积极的评级，普遍目标价格为 26.73 美元。Privia Health Group 的股票开盘价为 22.80 美元，市值为 27.7 亿美元。最近的内部交易显示首席财务官 David Mountcastle 出售了部分股份，减少了 3.04% 的持股比例</p>

<p>Privia Health Group (NASDAQ:PRVA - Get Free Report) had its target price boosted by stock analysts at Truist Financial from $27.00 to $28.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a &#34;buy&#34; rating on the stock. Truist Financial's target price points to a potential upside of 22.83% from the stock's previous close.</p>
<div class="lb-trans"><p>Privia Health Group（纳斯达克代码：PRVA - 获取免费报告）在周四发布的报告中，Truist Financial 的股票分析师将其目标价格从 27.00 美元上调至 28.00 美元，Benzinga 报道。该券商目前对该股票给予 “买入” 评级。Truist Financial 的目标价格意味着该股票相较于之前的收盘价有 22.83% 的潜在上涨空间。</p>
</div><p>Get <strong>Privia Health Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Privia Health Group</strong> 的提醒：</p>
</div><p>PRVA has been the topic of several other reports. Stephens reissued an &#34;overweight&#34; rating and set a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. Canaccord Genuity Group increased their target price on Privia Health Group from $29.00 to $30.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, February 28th. Macquarie started coverage on Privia Health Group in a research note on Monday, December 16th. They issued an &#34;outperform&#34; rating and a $25.00 price objective for the company. Piper Sandler raised their target price on Privia Health Group from $25.00 to $40.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, February 28th. Finally, JMP Securities set a $29.00 target price on Privia Health Group in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of &#34;Buy&#34; and a consensus target price of $26.73.</p>
<div class="lb-trans"><p>PRVA 近期成为多篇报告的主题。Stephens 在 1 月 2 日的报告中重新发布了 “超配” 评级，并将 Privia Health Group 的目标价格设定为 26.00 美元。Canaccord Genuity Group 在 2 月 28 日的研究报告中将 Privia Health Group 的目标价格从 29.00 美元上调至 30.00 美元，并给予该公司 “买入” 评级。Macquarie 在 12 月 16 日的研究报告中开始覆盖 Privia Health Group，给予 “跑赢大盘” 评级和 25.00 美元的价格目标。Piper Sandler 在 2 月 28 日的报告中将 Privia Health Group 的目标价格从 25.00 美元上调至 40.00 美元，并给予该公司 “超配” 评级。最后，JMP Securities 在 2 月 28 日的研究报告中将 Privia Health Group 的目标价格设定为 29.00 美元。一位股票研究分析师对该股票给予持有评级，十三位给予买入评级，两位给予强烈买入评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “买入”，共识目标价格为 26.73 美元。</p>
</div><p><strong>View Our Latest Stock Report on Privia Health Group</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Privia Health Group 的最新股票报告</strong></p>
</div><h2>Privia Health Group Trading Down 1.1 %</h2>
<div class="lb-trans"><h2>Privia Health Group 股价下跌 1.1%</h2>
</div><p>PRVA stock opened at $22.80 on Thursday. The business's 50 day simple moving average is $23.73 and its 200 day simple moving average is $21.41. Privia Health Group has a 1-year low of $15.92 and a 1-year high of $26.04. The firm has a market capitalization of $2.77 billion, a PE ratio of 227.97, a PEG ratio of 3.47 and a beta of 0.88.</p>
<div class="lb-trans"><p>PRVA 股票在周四开盘价为 22.80 美元。该公司的 50 日简单移动平均线为 23.73 美元，200 日简单移动平均线为 21.41 美元。Privia Health Group 的 1 年最低价为 15.92 美元，1 年最高价为 26.04 美元。该公司的市值为 27.7 亿美元，市盈率为 227.97，市盈增长比率为 3.47，贝塔值为 0.88。</p>
</div><h2>Insider Activity at Privia Health Group</h2>
<div class="lb-trans"><h2>Privia Health Group 的内部活动</h2>
</div><p>In other news, CFO David Mountcastle sold 5,630 shares of the firm's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the transaction, the chief financial officer now owns 179,676 shares in the company, valued at $4,021,148.88. This trade represents a 3.04 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 14.20% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新闻中，首席财务官 David Mountcastle 在 4 月 2 日（星期三）出售了 5,630 股公司的股票。股票以平均价格 22.38 美元出售，总价值为 125,999.40 美元。交易完成后，首席财务官现在持有 179,676 股公司股票，价值为 4,021,148.88 美元。此交易代表其持股减少了 3.04%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。公司内部人士目前持有 14.20% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently made changes to their positions in PRVA. Rhumbline Advisers increased its position in Privia Health Group by 1.3% during the 4th quarter. Rhumbline Advisers now owns 287,200 shares of the company's stock valued at $5,615,000 after buying an additional 3,658 shares in the last quarter. Nordea Investment Management AB increased its stake in Privia Health Group by 33.1% in the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock worth $6,953,000 after buying an additional 86,910 shares in the last quarter. Franklin Resources Inc. boosted its holdings in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock valued at $23,092,000 after purchasing an additional 28,480 shares during the last quarter. Barclays PLC grew its holdings in Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after buying an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase &amp; Co. grew its holdings in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase &amp; Co. now owns 188,384 shares of the company's stock valued at $3,430,000 after buying an additional 14,641 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近对 PRVA 的持仓进行了调整。Rhumbline Advisers 在第四季度将其在 Privia Health Group 的持仓增加了 1.3%。Rhumbline Advisers 现在持有 287,200 股公司股票，价值为 5,615,000 美元，此前在上个季度又购买了 3,658 股。Nordea Investment Management AB 在第四季度将其在 Privia Health Group 的股份增加了 33.1%。Nordea Investment Management AB 现在持有 349,773 股公司股票，价值为 6,953,000 美元，此前在上个季度又购买了 86,910 股。Franklin Resources Inc.在第三季度将其在 Privia Health Group 的持股增加了 2.2%。Franklin Resources Inc.现在持有 1,300,240 股公司股票，价值为 23,092,000 美元，此前在上个季度又购买了 28,480 股。巴克莱银行在第三季度将其在 Privia Health Group 的持股增加了 240.3%。巴克莱银行现在持有 224,018 股公司股票，价值为 4,079,000 美元，此前在上个季度又购买了 158,188 股。最后，摩根大通在第三季度将其在 Privia Health Group 的持股增加了 8.4%。摩根大通现在持有 188,384 股公司股票，价值为 3,430,000 美元，此前在上个季度又购买了 14,641 股。对冲基金和其他机构投资者持有公司 94.48% 的股票。</p>
</div><h2>About Privia Health Group</h2>
<div class="lb-trans"><h2>关于 Privia Health Group</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p>
<div class="lb-trans"><p>Privia Health Group, Inc 在美国作为一家全国性的医生赋能公司运营。该公司与医疗集团、健康计划和健康系统合作，以优化医生实践、提升患者体验，并奖励医生在面对面和虚拟环境中提供护理。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Privia Health Group</li>
<li>How the NYSE and NASDAQ are Different, Why That Matters to Investors</li>
<li>Broadcom's Big Outperformance Shows Strength Amid Tariff Decline</li>
<li>Election Stocks: How Elections Affect the Stock Market</li>
<li>Carvana: Can Turnaround Strength Outdrive Market Headwinds?</li>
<li>How to trade using analyst ratings</li>
<li>Meta Seeks Trump's Help in FTC Trial: The Implications Are Huge</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，优于 Privia Health Group</li>
<li>纽约证券交易所和纳斯达克的区别，以及这对投资者的重要性</li>
<li>博通的强劲表现显示出关税下降中的韧性</li>
<li>选举股票：选举如何影响股市</li>
<li>Carvana：能否在逆风中实现反转？</li>
<li>如何利用分析师评级进行交易</li>
<li>Meta 在 FTC 审判中寻求特朗普的帮助：影响巨大</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=PRVA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Privia Health Group 吗？</h2>
</div><p>Before you consider Privia Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Privia Health Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Privia Health Group 并不在名单上。</p>
</div><p>While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Privia Health Group 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Truist Financial 的分析师表示，Privia Health Group（纳斯达克股票代码：PRVA）的股价预计将上涨